Healthy Life Agritec Ltd (543546)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Healthy Life's revenue was ₹69.5 Cr (+62.6% year on year, -18.4% on the previous quarter), and net profit ₹1.4 Cr (+68.1% year on year); the operating margin was 3.3%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹69.5 | +62.6% | -18.4% |
| Operating profit | ₹2.3 | +72.9% | +20.5% |
| Net profit | ₹1.4 | +68.1% | +32.8% |
| EPS (₹) | 0.28 | +64.7% | +33.3% |
| Operating margin | 3.3% | — | — |
📢 Recent Corporate Announcements
Healthy Life Agritec Limited has postponed its Board meeting scheduled for September 29, 2026, which was convened to determine terms for an upcoming Rights Issue. The agenda included finalizing the issue price, entitlement ratio, and record date for the rights offering originally approved on September 23, 2025. The postponement is due to the pending in-principle approval from the Stock Exchange. The Board will reconvene within the next working day following receipt of the formal approval letter.
- Board meeting scheduled for September 29, 2026 postponed
- Postponement caused by pending in-principle approval from the Stock Exchange
- Agenda involves fixing issue price, entitlement ratio, and record date for Rights Issue approved on September 23, 2025
- Meeting to be rescheduled within the next working day post-receipt of exchange approval
Healthy Life Agritec has scheduled a Board of Directors meeting for September 29, 2026, to determine the specific terms of its proposed Rights Issue. The company had previously approved raising up to ₹5,000 lakhs (₹50 crore) via partly paid-up equity shares of face value ₹10 each. The proposed fundraise is massive relative to the company's current scale, representing approximately 156% of its market capitalization of ₹32 crore and 85% of its net worth of ₹59 crore. The meeting will decide the issue price, entitlement ratio, record date, and timing, subject to in-principle approval from BSE Limited.
- Board meeting scheduled for September 29, 2026, to decide Rights Issue terms
- Total Rights Issue size capped at an amount not exceeding ₹5,000 lakhs (₹50 crore)
- Issue structure entails partly paid-up equity shares with a face value of ₹10 each
- Proposed ₹50 crore fundraise equals ~156% of the company's current ₹32 crore market capitalization
- Implementation remains subject to in-principle approval from BSE Limited
The Board of Directors of Healthy Life Agritec Ltd has approved fundraising of up to ₹5,000 Lakhs (₹50 Cr) via a rights issue of partly paid-up equity shares with a face value of ₹10 each. The proposed issue size of ₹50 Cr is substantial, representing approximately 156% of the company's current market cap of ₹32 Cr and 85% of its net worth (₹59 Cr). The issue price, rights entitlement ratio, and record date will be finalized later by the newly formed Rights Issue Committee. The rights issue remains subject to necessary statutory and stock exchange approvals.
- Board approved raising funds up to ₹5,000 Lakhs (₹50 Cr) via a Rights Issue
- Securities proposed are partly paid-up equity shares of face value ₹10 each
- Fundraise amount of ₹50 Cr exceeds the company's current market capitalization of ₹32 Cr (~156%)
- Rights Issue Committee formed comprising Divya Mojjada, Mohammed Sadiq, and Apra Sharma
- Pricing, entitlement ratio, and record date are yet to be determined
The Board of Directors of Healthy Life Agritec Ltd has approved fundraising of up to ₹5,000 Lakhs (₹50 Cr) via a rights issue of partly paid-up equity shares with a face value of ₹10 each. The proposed issue size of ₹50 Cr is substantial, representing approximately 156% of the company's current market cap of ₹32 Cr and 85% of its net worth (₹59 Cr). The issue price, rights entitlement ratio, and record date will be finalized later by the newly formed Rights Issue Committee. The rights issue remains subject to necessary statutory and stock exchange approvals.
- Board approved raising funds up to ₹5,000 Lakhs (₹50 Cr) via a Rights Issue
- Securities proposed are partly paid-up equity shares of face value ₹10 each
- Fundraise amount of ₹50 Cr exceeds the company's current market capitalization of ₹32 Cr (~156%)
- Rights Issue Committee formed comprising Divya Mojjada, Mohammed Sadiq, and Apra Sharma
- Pricing, entitlement ratio, and record date are yet to be determined
Healthy Life Agritec reported a 68.1% YoY increase in consolidated net profit to Rs 1.39 Cr (Rs 139.49 lakhs) for the quarter ended June 30, 2026, compared to Rs 0.83 Cr in Q1 FY26. Consolidated revenue from operations grew 62.6% YoY to Rs 69.52 Cr (Rs 6,952.15 lakhs) from Rs 42.76 Cr, though it declined 18.4% QoQ against Rs 85.19 Cr in Q4 FY26. Basic EPS stood at Rs 0.28 for the quarter, compared to Rs 0.33 in the prior-year period due to the doubling of paid-up equity capital to Rs 49.62 Cr.
- Consolidated revenue from operations rose 62.6% YoY to Rs 6,952.15 lakhs (Rs 69.52 Cr) from Rs 4,276.33 lakhs in Q1 FY26.
- Consolidated PAT increased 68.1% YoY and 32.9% QoQ to Rs 139.49 lakhs (Rs 1.39 Cr) vs Rs 82.98 lakhs in Q1 FY26.
- Standalone revenue stood at Rs 2,840.99 lakhs with a standalone PAT of Rs 74.35 lakhs.
- Paid-up equity share capital doubled YoY to Rs 4,962.40 lakhs from Rs 2,481.20 lakhs in Q1 FY26.
Healthy Life Agritec reported a 68.1% YoY increase in consolidated net profit to ₹1.39 Cr (₹139.49 lakhs) for the quarter ended June 30, 2026, compared to ₹0.83 Cr in Q1 FY26. Consolidated revenue from operations grew 62.6% YoY to ₹69.52 Cr (₹6,952.15 lakhs) compared to ₹42.76 Cr in the prior-year period, though it contracted 18.4% sequentially from ₹85.19 Cr in Q4 FY26. Profit before tax rose 69.9% YoY to ₹1.89 Cr (₹188.78 lakhs) from ₹1.11 Cr in Q1 FY26. Basic and diluted EPS stood at ₹0.28 on an expanded equity share base of ₹49.62 Cr.
- Consolidated revenue from operations rose 62.6% YoY to ₹69.52 Cr (₹6,952.15 lakhs) vs ₹42.76 Cr in Q1 FY26
- Consolidated PAT increased 68.1% YoY and 32.9% QoQ to ₹1.39 Cr (₹139.49 lakhs)
- Profit Before Tax (PBT) expanded to ₹1.89 Cr (₹188.78 lakhs) vs ₹1.11 Cr in Q1 FY26
- Standalone revenue stood at ₹28.41 Cr with standalone net profit of ₹0.74 Cr
- Paid-up equity share capital was ₹49.62 Cr (doubled from ₹24.81 Cr in Q1 FY26)
Healthy Life Agritec has scheduled a board meeting on August 14, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. The company enters this quarter following a FY26 performance that saw revenue grow to ‡228 Cr with a net profit of ‡4 Cr. Investors will be closely watching for margin improvements, as the current operating margin stands at a thin 2.8%. The stock has faced significant pressure, declining 89.8% over the past 12 months, making the upcoming results critical for sentiment.
- Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results
- Trading window for insiders has been closed since July 01, 2026
- Company reported TTM revenue of ‡228 Cr against a small market cap of ‡28 Cr
- Operating profit margin remains low at 2.8% as per latest TTM data
- Promoter holding is relatively low at 28.86% as of June 2026
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
